Skip to main content

Advertisement

SpringerLink
Log in

Association Between ABO Blood Group and Fibrosis Severity in Chronic Hepatitis C Infection

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The progression of fibrosis in hepatitis C virus (HCV) infection is a process in which genes interact with environmental factors. A “clotting process” is involved in fibrogenesis. ABO blood group distribution is associated with thrombotic disease, non-O blood group increasing the risk of venous thrombosis. The aim of the study was to investigate whether ABO blood type contributes to the severity of fibrosis. We studied blood group distribution in 346 French patients with HCV infection who underwent biopsies. The distribution of non-O blood group was 40%, 55%, 62%, 71%, and 73% for the F0, F1, F2, F3 and F4 fibrosis scores, respectively. Non-O blood group was associated with increased severity of fibrosis, even after adjustment on gender, age, duration of infection, and alcohol consumption (odds ratio 1.8, 95% confidence interval 1.0–2.9; P=.04). Non-O blood group is an independent risk factor for the progression of liver fibrosis in HCV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36 (Suppl 1):S35–46

    Article  PubMed  Google Scholar 

  2. Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ (2003) Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52:404–409

    Article  PubMed  CAS  Google Scholar 

  3. Poujol-Robert A, Rosmorduc O, Serfaty L, Coulet F, Poupon R, Robert A (2004) Genetic and acquired thrombotic factors in chronic hepatitis C. Am J Gastroenterol 99:527–531

    Article  PubMed  Google Scholar 

  4. Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, Apple R, Cheng S, Thomas H, Thursz M (2003) Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 52:1206–1210

    Article  PubMed  CAS  Google Scholar 

  5. Poujol-Robert A, Boëlle PY, Poupon R, Robert A (2004) Activated protein C resistance (factor V Leiden) as a risk factor for cirrhosis in chronic hepatitis C patients. Hepatology 39:1174–1175

    Article  PubMed  CAS  Google Scholar 

  6. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J (1969) Venous thromboembolic disease and ABO blood group type. A cooperative study. Lancet 1:539–542

    Article  PubMed  CAS  Google Scholar 

  7. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–154

    Article  PubMed  CAS  Google Scholar 

  8. Robert A, Aillaud MF, Eschwege V, Randrianjohany A, Scarabin Y, Juhan-Vague I (2000) ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemostasis 83:630–631

    CAS  Google Scholar 

  9. The French Metavir Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15–20

    Google Scholar 

  10. Agresti A (1996) An introduction to categorical data analysis. John Wiley & Sons, New York

    Google Scholar 

  11. Harrell FE (2001) Regression modeling strategies. Springer, New York

    Google Scholar 

  12. Anstee QM, Wright M, Goldin R,et al. (2004) The factor V Leiden mutation accelerates disease progression in a mouse model of hepatic fibrosis induced by chronic carbon tetrachloride exposure. Hepatology 40;534A

    Google Scholar 

  13. Marra F, Grandaliano G, Valente AJ, Abboud HE (1995) Thrombin stimulates proliferation of liver fat-storing cells and expression of monocytes chemotactic protein-1: potential role in liver injury. Hepatology 22:780–787

    PubMed  CAS  Google Scholar 

  14. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G (1995) Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension. Hepatology 21:1238–1247

    PubMed  CAS  Google Scholar 

  15. Goodman ZD, Ishak KG (1982) Occlusive venous lesions in alcoholic liver disease. Gastroenterology 83:786–796

    PubMed  CAS  Google Scholar 

  16. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695

    PubMed  CAS  Google Scholar 

  17. Kraaijenhagen RA, in’t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Buller HR (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83:5–9

    PubMed  CAS  Google Scholar 

  18. Kamphuisen PW, Eikenboom JCJ, Bertina RM (2001) Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21:731–738

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Hépatologie, Hôpital Saint-Antoine Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, 184 rue du faubourg Saint Antoine, 75012, Paris, France

    Armelle Poujol-Robert & Raoul Poupon

  2. Service de Santé Publique, Hôpital Saint-Antoine Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France

    Pierre-Yves Boëlle

  3. Service d’Anatomie et Cytologie pathologiques Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France

    Dominique Wendum

  4. Service d’Immunologie et Hématologie Biologiques Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France

    Annie Robert

Authors
  1. Armelle Poujol-Robert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre-Yves Boëlle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dominique Wendum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raoul Poupon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Annie Robert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Armelle Poujol-Robert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poujol-Robert, A., Boëlle, PY., Wendum, D. et al. Association Between ABO Blood Group and Fibrosis Severity in Chronic Hepatitis C Infection. Dig Dis Sci 51, 1633–1636 (2006). https://doi.org/10.1007/s10620-006-9121-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9121-5

Keywords

Search

Navigation